Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 15
  • Journal CiteScore: 2.13
  • Journal Impact Factor: 1.45
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Wiedemann-Steiner syndrome with a novel compound heterozygous mutation in KMT2A gene having intellectual disability and microcephaly in a consanguineous family

Joint Event on 26th Edition of International Conference on Clinical Psychology and Neuroscience & 24th International Conference on Neuroscience and Neurochemistry
July 23-24, 2018 Birmingham, UK

Muhammad Imran Naseer, Fehmida Bibi, Mahmood Rasool, Angham Abdulrahman Abdulkareem, Adeel G Chaudhary and Mohammad H Al-Qahtani

King Abdulaziz University, KSA

Posters & Accepted Abstracts: J Neurol Neurosci


Wiedemann–Steiner syndrome (WSS) is an autosomal dominant disorder characterized by short stature, hypertrichosis, intellectual disability, developmental delay, along with facial dysmorphism. KMT2A gene (OMIM: 159555) is one of the known genes that are responsible for WSS and still new phenotypic features continue to be added in this conditions. Here in this study we report a novel compound heterozygous c.2017G>C (p.Ala673Pro) in exon 3 and c.3180G>T (p.Glu1060Asp), mutations in exon 4 of the KMT2A gene in two affected girls in Saudi family with microcephaly, speech disorders, walking difficulty and intellectual disability. Whole exome sequencing (WES) results showed two rare, missense variants in compound heterozygous state in the KMT2A gene in these two affected girls whereas the both the parents were heterozygous. A compound heterozygous c.2017G>C in exon 3 and c.3180G>T in exon 4 of the KMT2A mutation confirm the typical WSS phenotype. Furthermore, the WES results were validated by using the Sanger sequencing analysis in affected and parents along with 100 unrelated control from normal population. Our results showed similar type of genotype and phenotype of the patient is compared with the earlier reported patients in the literature, in an attempt to broaden our knowledge of this rare syndrome. Recent Publications 1. Aggarwal A, Rodriguez-Buritica DF and Northrup H (2017) Wiedemann-Steiner syndrome: Novel pathogenic variant and review of literature, European Journal of Medical Genetics 60(6):285-288. 2. Dunkerton S, Field M, Cho V, Bertram E, Whittle B, Groves A and Goel H (2015) A de novo Mutation in KMT2A (MLL) in monozygotic twins with Wiedemann-Steiner syndrome. American Journal of Medical Genetics Part A 167A(9):2182-7. 3. Enokizono T, Ohto T, Tanaka R, et al. (2017) Preaxial polydactyly in an individual with Wiedemann-Steine syndrome caused by a novel nonsense mutation in KMT2A, American Journal of Medical Genetics. Part A 173(10)2821-2825. 4. Miyake N, Tsurusaki Y, Koshimizu E, Okamoto N, et al. (2016) Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations. Clinical Genetics 89(1):115-9. 5. Sun Y, Hu G, Liu H, Zhang X, Huang Z, Yan H, Wang L, Fan Y, Gu X and Yu Y (2017) Further delineation of the phenotype of truncating KMT2A mutations: The extended Wiedemann-Steiner syndrome, American Journal of Medical Genetics. Part A 173(2):510-514.

Biography :

Muhammad Imran Naseer joined the CEGMR as a Neuroscientist from Gyeongsang National University, South Korea. His area of expertise includes molecular, cellular and developmental neuroscience. His PhD work was based on the effect of ethanol on siRNA-Mediated GABAB1 receptor expression for downstream signaling pathways, apoptotic neurodegeneration, maternal epileptic seizure and role of GABAB1 receptor expression in early development of pre and postnatal rat brain. Currently, he is involved in neurogenetic research program at CEGMR working on common neurologic disorders including Progressive Myoclonic, Juvenile Myoclonic, Idiopathic Generalized Epilepsy, microcephaly and other neurodegenerative and neurodevelopmental disorders in the western region of Saudi Arabia using microarray platform for array CGH, CNV/SNP analysis and next generation for expression and whole exome sequencing analysis. Further aim is to study the role of GABAB receptors and KIFs genes in early neurological defects related to neurodegenerative disorders in the Saudi Arabia including epilepsy, microcephaly, Alzheimer's and mental retardation.

E-mail: [email protected]